MedPath

Dasamia 80

Brand Name: Dasamia 80

Generic Name: Dasatinib

Active
Registration Number

DR-XY48568

Dosage Form

Film-Coated Tablet

Issuance Date

June 5, 2024

Expiry Date

January 18, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength80 mg
PackagingAlu/Alu blister pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic Agent (BCR-ABL Tyrosine Kinase Inhibitor)
A
Application
Monitored (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DasatinibActive
Monograph: Dasatinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform